Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$107.37
0.630.59%
At close: -
$106.25
-1.12-1.04%
After Hours: May 23, 7:45 PM EDT
Comments
Loading...
Gilead Sciences Analyst Ratings and Price Targets | NASDAQ:GILD | Benzinga
Gilead Sciences Inc has a consensus price target of $106.59 based on the ratings of 29 analysts. The high is $140 issued by Wells Fargo on March 5, 2025. The low is $69 issued by HSBC on April 24, 2024. The 3 most-recent analyst ratings were released by Mizuho, Oppenheimer, and Morgan Stanley on May 5, 2025, April 25, 2025, and April 25, 2025, respectively. With an average price target of $125.67 between Mizuho, Oppenheimer, and Morgan Stanley, there's an implied 18.27% upside for Gilead Sciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Mizuho
Oppenheimer
Morgan Stanley
Cantor Fitzgerald
BMO Capital
1calculated from analyst ratings
Analyst Ratings for Gilead Sciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/21/2025 | Buy Now | — | Needham | Joseph Stringer56% | — | Reiterates | Hold → Hold | Get Alert |
| 05/05/2025 | Buy Now | 10.11% | Mizuho | Salim Syed43% | $100 → $117 | Maintains | Outperform | Get Alert |
| 04/25/2025 | Buy Now | 17.64% | Oppenheimer | Hartaj Singh46% | $132 → $125 | Maintains | Outperform | Get Alert |
| 04/25/2025 | Buy Now | 27.05% | Morgan Stanley | Matthew Harrison61% | $130 → $135 | Maintains | Overweight | Get Alert |
| 04/25/2025 | Buy Now | — | Needham | Joseph Stringer56% | — | Reiterates | Hold → Hold | Get Alert |
| 04/22/2025 | Buy Now | 17.64% | Cantor Fitzgerald | Carter Gould57% | → $125 | Assumes | → Overweight | Get Alert |
| 04/17/2025 | Buy Now | 12.94% | BMO Capital | Evan Seigerman63% | $115 → $120 | Maintains | Outperform | Get Alert |
| 03/27/2025 | Buy Now | 22.35% | JP Morgan | Chris Schott59% | $120 → $130 | Maintains | Overweight | Get Alert |
| 03/11/2025 | Buy Now | 22.35% | Morgan Stanley | Matthew Harrison61% | $123 → $130 | Maintains | Overweight | Get Alert |
| 03/05/2025 | Buy Now | 18.58% | B of A Securities | Tim Anderson61% | $116 → $126 | Maintains | Buy | Get Alert |
| 03/05/2025 | Buy Now | 31.76% | Wells Fargo | Mohit Bansal67% | $120 → $140 | Maintains | Overweight | Get Alert |
| 03/04/2025 | Buy Now | 24.23% | Oppenheimer | Hartaj Singh46% | $115 → $132 | Maintains | Outperform | Get Alert |
| 02/18/2025 | Buy Now | 12.94% | Deutsche Bank | James Shin34% | $80 → $120 | Upgrade | Hold → Buy | Get Alert |
| 02/13/2025 | Buy Now | 9.17% | B of A Securities | Tim Anderson61% | $109 → $116 | Maintains | Buy | Get Alert |
| 02/12/2025 | Buy Now | 12.94% | JP Morgan | Chris Schott59% | $115 → $120 | Maintains | Overweight | Get Alert |
| 02/12/2025 | Buy Now | -5.89% | Baird | Brian Skorney57% | $95 → $100 | Maintains | Neutral | Get Alert |
| 02/12/2025 | Buy Now | -15.3% | RBC Capital | Brian Abrahams49% | $84 → $90 | Maintains | Sector Perform | Get Alert |
| 02/12/2025 | Buy Now | -9.65% | Goldman Sachs | Salveen Richter54% | $85 → $96 | Maintains | Neutral | Get Alert |
| 02/12/2025 | Buy Now | 8.23% | BMO Capital | Evan Seigerman63% | $110 → $115 | Maintains | Outperform | Get Alert |
| 02/12/2025 | Buy Now | 12.94% | Wells Fargo | Mohit Bansal67% | $105 → $120 | Maintains | Overweight | Get Alert |
| 02/12/2025 | Buy Now | 3.53% | Piper Sandler | Joseph Catanzaro43% | $105 → $110 | Maintains | Overweight | Get Alert |
| 02/12/2025 | Buy Now | 15.76% | Morgan Stanley | Matthew Harrison61% | $113 → $123 | Maintains | Overweight | Get Alert |
| 02/12/2025 | Buy Now | — | Needham | Joseph Stringer56% | — | Reiterates | Hold → Hold | Get Alert |
| 02/03/2025 | Buy Now | -20.94% | RBC Capital | Brian Abrahams49% | $84 → $84 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 01/29/2025 | Buy Now | 8.23% | JP Morgan | Chris Schott59% | $105 → $115 | Maintains | Overweight | Get Alert |
| 01/10/2025 | Buy Now | 6.35% | Morgan Stanley | Matthew Harrison61% | $87 → $113 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/11/2024 | Buy Now | -24.71% | Cantor Fitzgerald | Olivia Brayer53% | $80 → $80 | Reiterates | Neutral → Neutral | Get Alert |
| 12/11/2024 | Buy Now | -20.94% | RBC Capital | Brian Abrahams49% | $84 → $84 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 12/10/2024 | Buy Now | 8.23% | Oppenheimer | Matthew Biegler38% | $105 → $115 | Reiterates | Outperform → Outperform | Get Alert |
| 12/10/2024 | Buy Now | 2.58% | B of A Securities | Tim Anderson61% | → $109 | Reinstates | → Buy | Get Alert |
| 11/21/2024 | Buy Now | -9.65% | UBS | Colin Bristow38% | $70 → $96 | Maintains | Neutral | Get Alert |
| 11/21/2024 | Buy Now | -5.89% | Mizuho | Salim Syed43% | $90 → $100 | Maintains | Outperform | Get Alert |
| 11/18/2024 | Buy Now | -20.94% | RBC Capital | Brian Abrahams49% | $81 → $84 | Maintains | Sector Perform | Get Alert |
| 11/15/2024 | Buy Now | 3.53% | Wolfe Research | Alexandria Hammond42% | → $110 | Initiates | → Outperform | Get Alert |
| 11/14/2024 | Buy Now | 17.64% | Citigroup | Geoff Meacham61% | → $125 | Initiates | → Buy | Get Alert |
| 11/08/2024 | Buy Now | -18.12% | Morgan Stanley | Matthew Harrison61% | $84 → $87 | Maintains | Equal-Weight | Get Alert |
| 11/08/2024 | Buy Now | — | Maxim Group | Jason McCarthy42% | — | Downgrade | Buy → Hold | Get Alert |
| 11/08/2024 | Buy Now | -8.71% | Truist Securities | Asthika Goonewardene42% | $83 → $97 | Maintains | Hold | Get Alert |
| 11/07/2024 | Buy Now | -1.18% | Oppenheimer | Hartaj Singh46% | $95 → $105 | Maintains | Outperform | Get Alert |
| 11/07/2024 | Buy Now | -4% | BMO Capital | Evan Seigerman63% | $94 → $102 | Maintains | Outperform | Get Alert |
| 11/07/2024 | Buy Now | -10.59% | Baird | Brian Skorney57% | $80 → $95 | Maintains | Neutral | Get Alert |
| 11/07/2024 | Buy Now | -1.18% | JP Morgan | Chris Schott59% | $100 → $105 | Maintains | Overweight | Get Alert |
| 11/07/2024 | Buy Now | -23.77% | RBC Capital | Brian Abrahams49% | $75 → $81 | Maintains | Sector Perform | Get Alert |
| 11/07/2024 | Buy Now | -20.94% | Goldman Sachs | Salveen Richter54% | $74 → $84 | Maintains | Neutral | Get Alert |
| 11/07/2024 | Buy Now | -24.71% | Cantor Fitzgerald | Olivia Brayer53% | $70 → $80 | Maintains | Neutral | Get Alert |
| 11/07/2024 | Buy Now | -1.18% | Wells Fargo | Mohit Bansal67% | $100 → $105 | Maintains | Overweight | Get Alert |
| 11/07/2024 | Buy Now | -10.59% | Barclays | Carter Gould57% | $84 → $95 | Maintains | Equal-Weight | Get Alert |
| 11/07/2024 | Buy Now | -1.18% | Piper Sandler | Joseph Catanzaro43% | $95 → $105 | Maintains | Overweight | Get Alert |
| 11/07/2024 | Buy Now | — | Needham | Joseph Stringer56% | — | Reiterates | → Hold | Get Alert |
| 10/29/2024 | Buy Now | -29.41% | RBC Capital | Brian Abrahams49% | $75 → $75 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 10/21/2024 | Buy Now | -9.65% | Leerink Partners | Andrew Berens48% | $74 → $96 | Upgrade | Market Perform → Outperform | Get Alert |
| 10/17/2024 | Buy Now | -11.53% | BMO Capital | Evan Seigerman63% | $85 → $94 | Maintains | Outperform | Get Alert |
| 10/17/2024 | Buy Now | -1.18% | Bernstein | Aaron Gal53% | → $105 | Initiates | → Outperform | Get Alert |
| 10/09/2024 | Buy Now | -5.89% | JP Morgan | Chris Schott59% | $95 → $100 | Maintains | Overweight | Get Alert |
| 10/07/2024 | Buy Now | -20.94% | Barclays | Carter Gould57% | $76 → $84 | Maintains | Equal-Weight | Get Alert |
| 10/07/2024 | Buy Now | -5.89% | Wells Fargo | Mohit Bansal67% | $78 → $100 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/04/2024 | Buy Now | -29.41% | RBC Capital | Brian Abrahams49% | $74 → $75 | Maintains | Sector Perform | Get Alert |
| 09/16/2024 | Buy Now | -34.12% | Cantor Fitzgerald | Olivia Brayer53% | $70 → $70 | Reiterates | Neutral → Neutral | Get Alert |
| 09/11/2024 | Buy Now | -10.59% | Piper Sandler | Joseph Catanzaro43% | $95 → $95 | Maintains | Overweight | Get Alert |
| 09/09/2024 | Buy Now | -34.12% | Cantor Fitzgerald | Olivia Brayer53% | $70 → $70 | Reiterates | Neutral → Neutral | Get Alert |
| 09/04/2024 | Buy Now | -30.36% | RBC Capital | Brian Abrahams49% | $72 → $74 | Maintains | Sector Perform | Get Alert |
| 08/15/2024 | Buy Now | -21.89% | Truist Securities | Robyn Karnauskas54% | $82 → $83 | Maintains | Hold | Get Alert |
| 08/15/2024 | Buy Now | — | Needham | Joseph Stringer56% | — | Reiterates | → Hold | Get Alert |
| 08/09/2024 | Buy Now | -32.24% | RBC Capital | Brian Abrahams49% | $71 → $72 | Maintains | Sector Perform | Get Alert |
| 08/09/2024 | Buy Now | -34.12% | Cantor Fitzgerald | Olivia Brayer53% | $70 → $70 | Reiterates | Neutral → Neutral | Get Alert |
| 08/09/2024 | Buy Now | -20% | BMO Capital | Evan Seigerman63% | $80 → $85 | Maintains | Outperform | Get Alert |
| 07/22/2024 | Buy Now | -34.12% | Cantor Fitzgerald | Olivia Brayer53% | $75 → $70 | Maintains | Neutral | Get Alert |
| 07/08/2024 | Buy Now | -12.47% | Raymond James | Steven Seedhouse58% | → $93 | Upgrade | Market Perform → Outperform | Get Alert |
| 07/01/2024 | Buy Now | -30.36% | RBC Capital | Brian Abrahams49% | $74 → $74 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 06/20/2024 | Buy Now | -24.71% | Baird | Brian Skorney57% | $80 → $80 | Maintains | Neutral | Get Alert |
| 06/14/2024 | Buy Now | -30.36% | RBC Capital | Brian Abrahams49% | $74 → $74 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 04/29/2024 | Buy Now | -28.47% | Barclays | Carter Gould57% | $80 → $76 | Maintains | Equal-Weight | Get Alert |
| 04/26/2024 | Buy Now | -20% | TD Cowen | Tyler Van Buren45% | $90 → $85 | Maintains | Buy | Get Alert |
| 04/26/2024 | Buy Now | -26.59% | Morgan Stanley | Matthew Harrison61% | $80 → $78 | Maintains | Equal-Weight | Get Alert |
| 04/26/2024 | Buy Now | -30.36% | RBC Capital | Brian Abrahams49% | $76 → $74 | Maintains | Sector Perform | Get Alert |
| 04/26/2024 | Buy Now | — | Needham | Joseph Stringer56% | — | Reiterates | → Hold | Get Alert |
| 04/24/2024 | Buy Now | -35.06% | HSBC | Morten Herholdt39% | → $69 | Upgrade | Reduce → Hold | Get Alert |
| 04/19/2024 | Buy Now | -1.18% | Oppenheimer | Hartaj Singh46% | $105 → $105 | Maintains | Outperform | Get Alert |
| 04/17/2024 | Buy Now | -29.41% | UBS | Colin Bristow38% | $81 → $75 | Maintains | Neutral | Get Alert |
| 03/04/2024 | Buy Now | -26.59% | Wells Fargo | Mohit Bansal67% | $84 → $78 | Maintains | Equal-Weight | Get Alert |
| 02/22/2024 | Buy Now | -15.3% | Mizuho | Salim Syed43% | $101 → $90 | Maintains | Buy | Get Alert |
| 02/22/2024 | Buy Now | -22.83% | Truist Securities | Robyn Karnauskas54% | $91 → $82 | Downgrade | Buy → Hold | Get Alert |
| 02/14/2024 | Buy Now | -29.41% | RBC Capital | Brian Abrahams49% | $76 → $75 | Maintains | Sector Perform | Get Alert |
| 02/12/2024 | Buy Now | -24.71% | Barclays | Carter Gould57% | $85 → $80 | Maintains | Equal-Weight | Get Alert |
| 02/12/2024 | Buy Now | -1.18% | Oppenheimer | Hartaj Singh46% | $115 → $105 | Maintains | Outperform | Get Alert |
| 02/07/2024 | Buy Now | -26.59% | Cantor Fitzgerald | Olivia Brayer53% | $80 → $78 | Maintains | Neutral | Get Alert |
| 02/07/2024 | Buy Now | -28.47% | RBC Capital | Brian Abrahams49% | $78 → $76 | Maintains | Sector Perform | Get Alert |
| 02/07/2024 | Buy Now | -20.94% | Wells Fargo | Mohit Bansal67% | $90 → $84 | Maintains | Equal-Weight | Get Alert |
| 01/23/2024 | Buy Now | -20% | Barclays | Carter Gould57% | $82 → $85 | Maintains | Equal-Weight | Get Alert |
| 11/14/2023 | Buy Now | -27.53% | RBC Capital | Brian Abrahams49% | $78 → $77 | Maintains | Sector Perform | Get Alert |
| 11/09/2023 | Buy Now | -29.41% | Deutsche Bank | James Shin34% | → $75 | Initiates | → Hold | Get Alert |
| 09/08/2023 | Buy Now | -10.59% | B of A Securities | Geoff Meacham61% | $88 → $95 | Upgrade | Neutral → Buy | Get Alert |
| 09/06/2023 | Buy Now | -14.36% | Truist Securities | Robyn Karnauskas54% | → $91 | Reiterates | Buy → Buy | Get Alert |
| 09/06/2023 | Buy Now | -33.18% | HSBC | Morten Herholdt39% | → $71 | Initiates | → Reduce | Get Alert |
| 08/04/2023 | Buy Now | -17.18% | Morgan Stanley | Matthew Harrison61% | $86 → $88 | Maintains | Equal-Weight | Get Alert |
| 08/04/2023 | Buy Now | -20.94% | RBC Capital | Brian Abrahams49% | $83 → $84 | Maintains | Sector Perform | Get Alert |
| 07/24/2023 | Buy Now | -5.89% | Piper Sandler | Joseph Catanzaro43% | $105 → $100 | Maintains | Overweight | Get Alert |
| 07/24/2023 | Buy Now | -24.71% | Cantor Fitzgerald | Olivia Brayer53% | → $80 | Reiterates | Neutral → Neutral | Get Alert |
| 07/24/2023 | Buy Now | -24.71% | Barclays | Carter Gould57% | $81 → $80 | Maintains | Equal-Weight | Get Alert |
| 07/20/2023 | Buy Now | -24.71% | Cantor Fitzgerald | Olivia Brayer53% | $85 → $80 | Maintains | Neutral | Get Alert |
FAQ
What is the target price for Gilead Sciences (GILD) stock?
The latest price target for Gilead Sciences (NASDAQ:GILD) was reported by Needham on May 21, 2025. The analyst firm set a price target for $0.00 expecting GILD to fall to within 12 months (a possible -100.00% downside). 71 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Gilead Sciences (GILD)?
The latest analyst rating for Gilead Sciences (NASDAQ:GILD) was provided by Needham, and Gilead Sciences reiterated their hold rating.
When was the last upgrade for Gilead Sciences (GILD)?
The last upgrade for Gilead Sciences Inc happened on February 18, 2025 when Deutsche Bank raised their price target to $120. Deutsche Bank previously had a hold for Gilead Sciences Inc.
When was the last downgrade for Gilead Sciences (GILD)?
The last downgrade for Gilead Sciences Inc happened on November 8, 2024 when Maxim Group changed their price target from N/A to N/A for Gilead Sciences Inc.
When is the next analyst rating going to be posted or updated for Gilead Sciences (GILD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Gilead Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Gilead Sciences was filed on May 21, 2025 so you should expect the next rating to be made available sometime around May 21, 2026.
Is the Analyst Rating Gilead Sciences (GILD) correct?
While ratings are subjective and will change, the latest Gilead Sciences (GILD) rating was a reiterated with a price target of $0.00 to $0.00. The current price Gilead Sciences (GILD) is trading at is $106.25, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
